0001209191-21-060361.txt : 20211013
0001209191-21-060361.hdr.sgml : 20211013
20211013161938
ACCESSION NUMBER: 0001209191-21-060361
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211012
FILED AS OF DATE: 20211013
DATE AS OF CHANGE: 20211013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aftab Blake
CENTRAL INDEX KEY: 0001886986
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 211321402
MAIL ADDRESS:
STREET 1: C/O ADICET BIO, INC.
STREET 2: 200 CLARENDON STREET, FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
STREET 2: FLOOR 6
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-10-12
0
0001720580
Adicet Bio, Inc.
ACET
0001886986
Aftab Blake
C/O ADICET BIO, INC.
200 CLARENDON STREET
BOSTON
MA
02116
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
15.93
2031-04-29
Common Stock
50000
D
25% of the shares shall vest on the first anniversary of April 5, 2021 (the "Vesting Commencement Date") and as to the remaining 75% of such shares in thirty-six (36) equal monthly installments following the first anniversary of the Vesting Commencement Date; provided that the option holder remains continuously engaged by the Company on each such date.
/s/ Nick Harvey, as Attorney-in-Fact
2021-10-13